CAPR
CAPR clinical trials: CAPRICOR THERAPEUTICS, INC.
Every trial on ClinicalTrials.gov where CAPRICOR THERAPEUTICS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 12
- Trials linked
- 11
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CAPR on the catalyst calendar · CAPR registry changes
- Primary completion Jun 18, 2025ActualPhase 3NCT05126758A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyCapricor Inc. · Muscular DystrophiesActive, not recruitingCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 16, 2022ActualPhase 2NCT04428476Open-label Extension of the HOPE-2 TrialCapricor Inc. · Duchenne Muscular DystrophyActive, not recruitingCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2020ActualPhase 2NCT03406780A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyCapricor Inc. · Muscular DystrophiesCompletedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 4, 2022ActualPhase 2NCT04623671Intravenous Infusion of CAP-1002 in Patients With COVID-19Capricor Inc. · Covid19CompletedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 14, 2017ActualPhase 2NCT02485938HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)Capricor Inc. · Duchenne Muscular DystrophyCompletedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 6, 2019ActualPhase 2NCT06304064Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)Capricor Inc. · Duchenne Muscular DystrophyCompletedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 3, 2017ActualPhase 1/Phase 2NCT01458405Allogeneic Heart Stem Cells to Achieve Myocardial RegenerationCapricor Inc. · Myocardial InfarctionTerminatedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT04338347CAP-1002 in Severe COVID-19 DiseaseCapricor Inc. · COVID-19No longer availableCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2016ActualPhase 1/Phase 2NCT02603614Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal ImpairmentCapricor Inc. · Heart FailureCompletedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2, 2015ActualPhase 2NCT02359227Safety Study of Cenderitide in Stable Chronic Heart FailureCapricor Inc. · Heart FailureCompletedCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2015ActualPhase 1NCT02293603Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)Capricor Inc. · Dilated Cardiomyopathy (DCM)Unknown statusCAPRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 15, 2019ActualNo phase registeredNCT03680365Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of FamiliesJett Foundation, Inc. · Duchenne Muscular Dystrophy
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 12 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner